How to buy The Chemours Company stock | $30.64

The Chemours Company is a specialty chemicals business based in the US. The Chemours Company shares (CC) are listed on the NYSE and all prices are listed in US Dollars. The Chemours Company employs 6,500 staff and has a trailing 12-month revenue of around 0.00.

The Chemours Company stock price (NYSE: CC)

Use our graph to track the performance of CC stocks over time.

The Chemours Company shares at a glance

• Key figures

Information last updated 2021-10-16.

Latest market close	$30.64
52-week range	$18.83 - $37.67
50-day moving average	$30.68
200-day moving average	$32.49
Wall St. target price	$40.83
PE ratio	20.269
Dividend yield	$1 (3.23%)
Earnings per share (TTM)	$1.52

Buy The Chemours Company shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy The Chemours Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

The Chemours Company price performance over time

Historical closes compared with the close of $30.64 from 2021-10-18

1 week (2021-10-12)	-0.87%
1 month (2021-09-17)	2.99%
3 months (2021-07-19)	-0.78%
6 months (2021-04-19)	2.65%

1 year (2020-10-19)	35.04%
2 years (2019-10-18)	102.24%
3 years (2018-10-19)	35.87
5 years (2016-10-19)	88.90%

Is The Chemours Company under- or over-valued?

Valuing The Chemours Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Chemours Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

The Chemours Company's P/E ratio

The Chemours Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, The Chemours Company shares trade at around 20x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

The Chemours Company's PEG ratio

The Chemours Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 8.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Chemours Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

The Chemours Company's EBITDA

The Chemours Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $785 million.

The EBITDA is a measure of a The Chemours Company's overall financial performance and is widely used to measure a its profitability.

The Chemours Company financials

Revenue TTM	$5.7 billion
Operating margin TTM	8.16%
Gross profit TTM	$1.1 billion
Return on assets TTM	3.98%
Return on equity TTM	32.84%
Profit margin	4.52%
Book value	$5.43
Market capitalisation	$5.1 billion

TTM: trailing 12 months

Shorting The Chemours Company shares

There are currently 9.4 million The Chemours Company shares held short by investors – that's known as The Chemours Company's "short interest". This figure is 29.1% up from 7.2 million last month.

There are a few different ways that this level of interest in shorting The Chemours Company shares can be evaluated.

The Chemours Company's "short interest ratio" (SIR)

The Chemours Company's "short interest ratio" (SIR) is the quantity of The Chemours Company shares currently shorted divided by the average quantity of The Chemours Company shares traded daily (recently around 1.8 million). The Chemours Company's SIR currently stands at 5.19. In other words for every 100,000 The Chemours Company shares traded daily on the market, roughly 5190 shares are currently held short.

However The Chemours Company's short interest can also be evaluated against the total number of The Chemours Company shares, or, against the total number of tradable The Chemours Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Chemours Company's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 The Chemours Company shares in existence, roughly 60 shares are currently held short) or 0.0605% of the tradable shares (for every 100,000 tradable The Chemours Company shares, roughly 61 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against The Chemours Company.

Find out more about how you can short The Chemours Company stock.

The Chemours Company share dividends

Dividend payout ratio: 33.33% of net profits

Recently The Chemours Company has paid out, on average, around 33.33% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Chemours Company shareholders could enjoy a 3.23% return on their shares, in the form of dividend payments. In The Chemours Company's case, that would currently equate to about $1 per share.

While The Chemours Company's payout ratio might seem fairly standard, it's worth remembering that The Chemours Company may be investing much of the rest of its net profits in future growth.

The Chemours Company's most recent dividend payout was on 14 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 12 August 2021 (the "ex-dividend date").

The Chemours Company share price volatility

Over the last 12 months, The Chemours Company's shares have ranged in value from as little as $18.8333 up to $37.6745. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Chemours Company's is 2.1794. This would suggest that The Chemours Company's shares are significantly more volatile than the average for this exchange and represent a higher risk.

The Chemours Company overview

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications. The Thermal & Specialized Solutions segment offers of refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment provides polymers and advanced materials. Its Chemical Solutions segment offers industrial chemicals used in gold production, industrial, and consumer applications. The company sells its products through direct channels, as well as through a network of resellers and distributors.

Frequently asked questions

What percentage of The Chemours Company is owned by insiders or institutions?
Currently 0.968% of The Chemours Company shares are held by insiders and 77.823% by institutions. How many people work for The Chemours Company?
Latest data suggests 6,500 work at The Chemours Company. When does the fiscal year end for The Chemours Company?
The Chemours Company's fiscal year ends in December. Where is The Chemours Company based?
The Chemours Company's address is: 1007 Market Street, Wilmington, DE, United States, 19899 What is The Chemours Company's ISIN number?
The Chemours Company's international securities identification number is: US1638511089 What is The Chemours Company's CUSIP number?
The Chemours Company's Committee on Uniform Securities Identification Procedures number is: 163851108